UPDATED PROGRESSION-FREE SURVIVAL (PFS) AND DEPTH OF RESPONSE IN IKEMA, A RANDOMIZED PHASE 3 TRIAL OF ISATUXIMAB, CARFILZOMIB AND DEXAMETHASONE (ISA-KD) VS KD IN RELAPSED MULTIPLE MYELOMA (MM) Ozgur PEKTAS; Philippe MOREAU; Meletios-Athanasios DIMOPOULOS; Joseph MIKHAEL; Kwee YONG; Marcelo CAPRA; Thierry FACON; Roman HAJEK; Ivan ¿PI¿KA; France CASCA; Sandrine MACÉ; Marie-Laure RISSE; Thomas MARTIN;